Evolving Treatments of Metastatic CRC: Insights from ASCO 2024 - Episode 5
Existing Challenges for Patients Receiving 3L+ Therapies in mCRC July 10, 2024
John Marshall, MD , Al B. Benson III, MD, FACP, FACCC, FASCO , Kristen Ciombor, MD, MSCI , Stacey A. Cohen, MD , Marwan Fakih, MD
The colorectal cancer experts offer insights on a patient case and investigate the obstacles faced by patients with metastatic colorectal cancer requiring third-line or later therapy.
Dr Marshall to Panel: Briefly provide comments and perspectives on this patient case. Dr Marshall to Dr Ciombor: What present challenges exist for patients with mCRC requiring 3L+ therapy?With evolving data and latest approvals, have we gotten closer to addressing those challenges and if so, how?